carmustine has been researched along with Remission, Spontaneous in 75 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two hundred and ninety-eight evaluable patients with non-Hodgkin's lymphoma were stratified according to histology, treated with either BCNU, cyclophosphamide, Oncovin (vincristine), and prednisone (BCOP) or cyclophosphamide, Oncovin (vincristine), and prednisone (COP), and evaluated at 3 months." | 9.04 | BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma. ( Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA, 1977) |
| "Fourteen patients with multiple myeloma resistant to melphalan plus prednisone were treated with BCNU 50 mg/m2 plus cyclophosphamide 200 mg/m2 on day 1, adriamycin 20 mg/m2 on day 2 and prednisone 60 mg orally, daily for days 1 through 5." | 7.66 | Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma. ( Klahr, C; Presant, CA, 1978) |
| "One hundred twenty-one patients with disseminated malignant melanoma were treated with BCNU, vincristine, DTIC, and chlorpromazine (BVD)." | 7.65 | Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. ( Bodey, GP; Lane, M; Luce, JK; McKelvey, EM; Moon, TE; Talley, RW; Vaitkevicius, VK, 1977) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 7.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| "Two hundred and ninety-eight evaluable patients with non-Hodgkin's lymphoma were stratified according to histology, treated with either BCNU, cyclophosphamide, Oncovin (vincristine), and prednisone (BCOP) or cyclophosphamide, Oncovin (vincristine), and prednisone (COP), and evaluated at 3 months." | 5.04 | BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma. ( Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA, 1977) |
| "A number of cooperative-group and single-institution studies have shown that BCNU used in combination with prednisone alone or with melphalan,cyclophosphamide, and prednisone is useful for remission induction in patients with previously untreated multiple myeloma." | 5.04 | Nitrosoureas in multiple myeloma. ( Salmon, SE, 1976) |
| "The effects of various regimens of melphalan combination chemotherapy were evaluated in 508 patients with multiple myeloma." | 5.04 | Remission maintenance therapy for multiple myeloma. ( , 1975) |
| "In the histiocytic lymphomas, BCNU added to CVP increases the percentage of CRs but it does so at the expense of considerable toxicity." | 3.74 | Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience. ( Bennett, JM; Carbone, PP; Ezdinli, E; Johnson, GJ; Lenhard, RE; Pocock, SJ, 1977) |
| "37 consecutive, previously untreated patients with advanced multiple myeloma (16 patients Stage II, 21 patients Stage III) were treated with a five drug regimen consisting of carmustine, melphalan, vincristine, cyclophosphamide and prednisolone (M-2-protocol) in a prospective manner." | 3.67 | Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma. ( Bauer, K; Bettelheim, P; Gössinger, H; Hinterberger, W; Korninger, K; Lechner, K; Neumann, E; Niessner, H; Pabinger-Fasching, I, 1984) |
| "Fourteen patients with multiple myeloma resistant to melphalan plus prednisone were treated with BCNU 50 mg/m2 plus cyclophosphamide 200 mg/m2 on day 1, adriamycin 20 mg/m2 on day 2 and prednisone 60 mg orally, daily for days 1 through 5." | 3.66 | Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma. ( Klahr, C; Presant, CA, 1978) |
| "Five children with recurrent medulloblastomas were treated with Vincristine, BCNU, Methotrexate and Dexamethasone." | 3.66 | Combination chemotherapy in recurrent medulloblastoma. ( Cohen, ME; Duffner, PK; Freeman, AI; Sinks, LF; Thomas, PR, 1979) |
| "One hundred twenty-one patients with disseminated malignant melanoma were treated with BCNU, vincristine, DTIC, and chlorpromazine (BVD)." | 3.65 | Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. ( Bodey, GP; Lane, M; Luce, JK; McKelvey, EM; Moon, TE; Talley, RW; Vaitkevicius, VK, 1977) |
| "Sixty-seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses." | 3.65 | 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma. ( Chan, YK; Dorfman, R; Durant, JR; Loeb, V, 1975) |
| "The incidence of brain metastases was neither lowered nor delayed by the presence of BCNU in regimens A and C." | 2.64 | Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. ( Beretta, G; Bonadonna, G; Cascinelli, N; Morabito, A; Veronesi, U, 1976) |
| "Six children with grade II astrocytomas were treated with combination chemotherapy consisting of 1,3 bis(2-chloroethyl) 1-nitrosourea (BCNU)." | 1.26 | Chemotherapy in recurrent noncystic low-grade astrocytomas of the cerebrum in children. ( Bremer, AM; Cohen, M; Freeman, AI; Sinks, LF; Sumer, T; Thomas, PR, 1978) |
| "Fourteen patients with American Burkitt's lymphoma resistant to conventional chemotherapy were treated with high-dose combination chemotherapy and intensive supportive care." | 1.26 | Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. ( Appelbaum, FR; Deisseroth, AB; Graw, RG; Herzig, GP; Levine, AS; Magrath, IT; Pizzo, PA; Poplack, DG; Ziegler, JL, 1978) |
| "The therapy of cancer of the colon still remains unsatisfactory: the rate of remissions could be increased, but survival remains unaltered." | 1.26 | [Current state of therapy for gastrointestinal tumors]. ( Hartmann, D; Obrecht, JP, 1978) |
| "Skin, lymph node, and soft tissue metastases more frequently responded to therapy, while hepatic, peritoneal, and osseous metastases responded with an intermediate frequency." | 1.26 | Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma. ( Klahr, C; Presant, CA; Van Amburg, A, 1977) |
| "All patients had extensive metastases in soft tissues, intestines and, some of them, in bone." | 1.26 | [Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)]. ( Kleeberg, UR; Schreml, W, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 75 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gössinger, H | 1 |
| Bettelheim, P | 1 |
| Neumann, E | 1 |
| Hinterberger, W | 1 |
| Korninger, K | 1 |
| Niessner, H | 1 |
| Pabinger-Fasching, I | 1 |
| Bauer, K | 1 |
| Lechner, K | 1 |
| Ghanta, VK | 1 |
| Hiramoto, RN | 1 |
| Davis, DW | 1 |
| Hiramoto, NS | 1 |
| Alberts, DS | 1 |
| Durie, BG | 1 |
| Salmon, SE | 2 |
| Bennett, JM | 3 |
| Lenhard, RE | 4 |
| Ezdinli, E | 2 |
| Johnson, GJ | 1 |
| Carbone, PP | 4 |
| Pocock, SJ | 1 |
| Pettavel, J | 1 |
| Morgenthaler, FR | 1 |
| Zackheim, HS | 1 |
| Epstein, EH | 1 |
| Grekin, DA | 1 |
| Levin, VA | 1 |
| Hoffman, WF | 1 |
| Pischer, TL | 1 |
| Seager, ML | 1 |
| Boldrey, EB | 1 |
| Wilson, CB | 1 |
| Abeloff, MD | 1 |
| Ettinger, DS | 1 |
| Khouri, NF | 1 |
| Presant, CA | 3 |
| Ratkin, G | 1 |
| Klahr, C | 3 |
| Brown, C | 1 |
| Kung, FH | 1 |
| Nythan, WL | 1 |
| Cuttner, J | 2 |
| Falkson, G | 4 |
| Lanzkowsky, P | 1 |
| Del Duca, V | 1 |
| Nawabi, IU | 1 |
| Koch, K | 1 |
| Pluess, H | 1 |
| Freeman, A | 1 |
| Burgert, EO | 1 |
| Leone, LA | 1 |
| Ruymann, F | 1 |
| Patterson, RB | 1 |
| Degnan, T | 1 |
| Hakami, N | 1 |
| Pajak, TF | 2 |
| Holland, J | 1 |
| Durant, JR | 3 |
| Gams, RA | 2 |
| Bartolucci, AA | 1 |
| Dorfman, RF | 1 |
| Ezdinli, EZ | 2 |
| Costello, W | 2 |
| Horton, J | 1 |
| Amorisi, EL | 1 |
| Stolbach, L | 1 |
| Wolter, J | 1 |
| Nissen, NI | 1 |
| Glidewell, O | 2 |
| Pedersen-Bjergaard, J | 1 |
| Stutzman, L | 2 |
| Blom, J | 1 |
| Leone, L | 1 |
| Sawitsky, A | 1 |
| Coleman, M | 1 |
| Haurani, F | 1 |
| Spurr, CL | 1 |
| Harley, JB | 1 |
| Seligman, B | 1 |
| Cornell, C | 1 |
| Henry, P | 1 |
| Senn, HJ | 2 |
| Brunner, K | 1 |
| Martz, G | 2 |
| Maurice, P | 2 |
| Bank, A | 1 |
| Shapiro, L | 1 |
| James, GW | 1 |
| Holland, JF | 2 |
| Hall, SW | 1 |
| Benjamin, RS | 1 |
| Murphy, WK | 1 |
| Valdivieso, M | 1 |
| Bodey, GP | 2 |
| Yamada, K | 1 |
| Bremer, AM | 2 |
| West, CR | 1 |
| Ghoorah, J | 1 |
| Park, HC | 1 |
| Takita, H | 1 |
| Icli, F | 1 |
| Berard, CW | 1 |
| Alexanian, R | 1 |
| Salmon, S | 1 |
| Bonnet, J | 1 |
| Gehan, E | 1 |
| Haut, A | 1 |
| Weick, J | 1 |
| Case, DC | 1 |
| Lee, DJ | 1 |
| Clarkson, BD | 4 |
| Sumer, T | 1 |
| Freeman, AI | 2 |
| Cohen, M | 1 |
| Thomas, PR | 2 |
| Sinks, LF | 2 |
| Murphy, S | 1 |
| Appelbaum, FR | 1 |
| Deisseroth, AB | 1 |
| Graw, RG | 1 |
| Herzig, GP | 1 |
| Levine, AS | 1 |
| Magrath, IT | 1 |
| Pizzo, PA | 1 |
| Poplack, DG | 1 |
| Ziegler, JL | 1 |
| Hartmann, D | 1 |
| Obrecht, JP | 2 |
| Velez-Garcia, E | 1 |
| Bartolucci, A | 1 |
| Wirtschafter, D | 1 |
| Dorfman, R | 2 |
| Duffner, PK | 1 |
| Cohen, ME | 1 |
| Comis, RL | 1 |
| Costanzi, JJ | 1 |
| Anderson, T | 1 |
| DeVita, T | 1 |
| Young, RC | 2 |
| Bergsagel, DE | 3 |
| Pruzanski, W | 1 |
| McKelvey, EM | 2 |
| Luce, JK | 2 |
| Talley, RW | 2 |
| Hersh, EM | 2 |
| Hewlett, JS | 1 |
| Moon, TE | 2 |
| Vaitkevicius, VK | 1 |
| Lane, M | 1 |
| Van Amburg, A | 1 |
| Moertel, CG | 2 |
| Kaufman, JH | 1 |
| Aungst, CW | 2 |
| von Eyben, FE | 1 |
| Larsen, V | 1 |
| Pedersen, H | 1 |
| Beretta, G | 1 |
| Bonadonna, G | 1 |
| Cascinelli, N | 1 |
| Morabito, A | 1 |
| Veronesi, U | 1 |
| Brufman, G | 1 |
| Biran, S | 1 |
| Ratzkowski, E | 1 |
| Dowling, MD | 2 |
| Gee, TS | 2 |
| Cunningham, IB | 1 |
| Burchenal, JH | 2 |
| Haghbin, M | 2 |
| Cunningham, I | 1 |
| Middleman, MP | 1 |
| Loeb, V | 1 |
| Chan, YK | 1 |
| Perk, K | 1 |
| Chirigos, MA | 6 |
| Fuhrman, F | 2 |
| Pettigrew, H | 1 |
| Pryor, J | 2 |
| Van Dyk, JJ | 1 |
| Kleeberg, UR | 1 |
| Schreml, W | 1 |
| Carter, SK | 2 |
| Goldsmith, MA | 1 |
| Desser, RK | 1 |
| Ultmann, JE | 1 |
| Schabel, FM | 2 |
| Skipper, HE | 1 |
| Trader, MW | 1 |
| Laster, WR | 1 |
| Cheeks, JB | 1 |
| Frei, E | 1 |
| Goldin, A | 1 |
| Tan, CC | 1 |
| Miké, V | 1 |
| Murphy, ML | 1 |
| Sonntag, R | 1 |
| Favre, E | 1 |
| De Vita, VT | 1 |
| Canellos, GP | 1 |
| Schein, PJ | 1 |
| Chabner, BA | 1 |
| Bagley, CM | 1 |
| Pearson, JW | 4 |
| Chaparas, SD | 3 |
| Sher, NA | 1 |
| DeVita, VT | 2 |
| Chirigos, M | 1 |
| Pearson, J | 1 |
| Sher, N | 1 |
| van Eden, EB | 1 |
| Falkson, HC | 1 |
| Brunner, KW | 1 |
| Sonntag, RW | 1 |
| Teller, MN | 1 |
| Bowie, M | 1 |
| Mountain, IM | 1 |
| Gutterman, JU | 1 |
| Mavligit, G | 1 |
| Gottlieb, JA | 1 |
| Burgess, MA | 1 |
| McBride, CE | 1 |
| Einhorn, L | 1 |
| Freireich, EJ | 1 |
| Fairley, GH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A National, Multi-Center, Open-Label Study of Velcade in Combination With Melphalan and Prednisone (V-MP) in Older Untreated Multiple Myeloma Patients.[NCT00388635] | Phase 1/Phase 2 | 60 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| VELCADEXA: A National, Multi-Center, Open-Label Study of Pretransplant Induction With Alternating VELCADE and Dexamethasone (VEL/Dex) in Younger (< 65 Yrs) Untreated Multiple Myeloma Patients.[NCT00391157] | Phase 2 | 40 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors[NCT00001301] | 107 participants | Observational | 1992-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for carmustine and Remission, Spontaneous
| Article | Year |
|---|---|
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ad | 1977 |
DTIC (NSC-45388) in malignant melanoma: a perspective.
Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; | 1976 |
The treatment of plasma cell myeloma.
Topics: Animals; Carmustine; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Me | 1976 |
Current status of new agents.
Topics: Alopecia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Azaguanine; Carm | 1972 |
Combination chemotherapy of advanced Hodgkin's disease. A review.
Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; H | 1974 |
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmu | 1973 |
Plasma cell myeloma. An interpretive review.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Carmustine; Cell Division; Cyclophosphamide; Drug Re | 1972 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dru | 1972 |
Current chemotherapeutic combinations.
Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Drug Evaluation; Drug Therapy, Co | 1973 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin | 1971 |
18 trials available for carmustine and Remission, Spontaneous
| Article | Year |
|---|---|
Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Topics: Altretamine; Bleomycin; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Ad | 1977 |
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Ch | 1978 |
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combin | 1977 |
Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Cyclophosphamide; Drug Evaluation; Drug | 1978 |
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal | 1979 |
Combination therapy for multiple myeloma.
Topics: Antineoplastic Agents; Azathioprine; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combin | 1977 |
BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Child; Cyclophosphamide; Dr | 1978 |
DTIC (NSC-45388) in malignant melanoma: a perspective.
Topics: Animals; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; | 1976 |
DTIC (NSC-45388) studies in the southwest oncology group.
Topics: Carmustine; Chlorpromazine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Co | 1976 |
BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease: its role in remission induction and maintenance.
Topics: Bacterial Infections; Bone Marrow; Carmustine; Clinical Trials as Topic; Hodgkin Disease; Humans; Re | 1976 |
Nitrosoureas in multiple myeloma.
Topics: Carmustine; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Human | 1976 |
Lymphosarcoma. A comparison of extended to conservative chemotherapy.
Topics: Adult; Aged; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; | 1976 |
Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carmustine; Central Nervous System | 1976 |
Remission maintenance therapy for multiple myeloma.
Topics: Bone Neoplasms; Carmustine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; | 1975 |
Chemotherapy of acute lymphocytic leukemia of childhood.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Carmustine; Cell Division; Cell Transformati | 1972 |
[Therapeutic experiences in multiple myeloma].
Topics: Aniline Compounds; Antineoplastic Agents; Blood Sedimentation; Carmustine; Clinical Trials as Topic; | 1972 |
Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
Topics: Alopecia; Amides; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Colonic Neoplasms; Dr | 1974 |
[On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
Topics: Carmustine; Chlorambucil; Cyclohexanes; Drug Resistance; Drug Synergism; Hodgkin Disease; Humans; Ni | 1972 |
49 other studies available for carmustine and Remission, Spontaneous
| Article | Year |
|---|---|
Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Therapy, Co | 1984 |
Maintenance of MOPC 104E myeloma in plateau phase.
Topics: Animals; Antineoplastic Agents; Carmustine; Cisplatin; Cyclophosphamide; Dose-Response Relationship, | 1980 |
Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse.
Topics: Alkylating Agents; Blood Cell Count; Carmustine; Cell Count; Doxorubicin; Drug Therapy, Combination; | 1976 |
[Treatment of primary and secondary liver tumors using a combination of chemotherapy and surgery].
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Floxuridine; Fluorouracil; Humans; Leu | 1975 |
Treatment of mycosis fungoides with topical BCNU.
Topics: Administration, Topical; Bone Marrow; Carmustine; Drug Eruptions; Humans; Mycosis Fungoides; Remissi | 1979 |
BCNU-5-fluorouracil combination therapy for recurrent malignant brain tumors.
Topics: Astrocytoma; Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Fluorouracil; Glio | 1978 |
Intensive induction therapy for small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxor | 1979 |
Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
Topics: Antineoplastic Agents; Bone Marrow; Carcinoma, Adenoid Cystic; Carcinoma, Squamous Cell; Carmustine; | 1979 |
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer.
Topics: Adult; Aged; Biliary Tract Neoplasms; Bone Marrow; Carmustine; Doxorubicin; Drug Therapy, Combinatio | 1979 |
Intra-arterial BCNU therapy in the treatment of metastatic brain tumor from lung carcinoma: a preliminary report.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Carotid Arteries; Female; Humans; Infusions, Intra-Arteria | 1979 |
Diffuse well-differentiated lymphocytic lymphoma (DLWD): response and survival.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Differentiation; Chlorambucil; Cyclophosphamide; Drug | 1978 |
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immu | 1977 |
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immu | 1977 |
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immu | 1977 |
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immu | 1977 |
Chemotherapy in recurrent noncystic low-grade astrocytomas of the cerebrum in children.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethas | 1978 |
L2C guinea pig leukemia. A potential model for structuring multimodality therapy.
Topics: Animals; BCG Vaccine; Carmustine; Cyclophosphamide; Disease Models, Animal; Female; Freund's Adjuvan | 1978 |
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.
Topics: Adolescent; Adult; Burkitt Lymphoma; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabi | 1978 |
[Current state of therapy for gastrointestinal tumors].
Topics: Carmustine; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; | 1978 |
Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Carmustine; Cyclophosphamide; Doxorubicin; Drug Resistance | 1978 |
Combination chemotherapy in recurrent medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethaso | 1979 |
Treatment of plasma cell myeloma with cytotoxic agents.
Topics: Acute Disease; Alkylating Agents; Bence Jones Protein; Bone Neoplasms; Carmustine; Cell Count; Cyclo | 1975 |
Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
Topics: Carmustine; Dacarbazine; Drug Therapy, Combination; Eosinophils; Female; Humans; Leukocyte Count; Ly | 1977 |
Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
Topics: Carmustine; Chlorpromazine; Dacarbazine; Drug Therapy, Combination; Eosinophils; Female; Humans; Leu | 1977 |
Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Ascites; Bone Neoplasms; Breast Neoplasms; Carmustine; | 1977 |
Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
Topics: Carmustine; Colonic Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neo | 1976 |
[Results of plasmacytoma therapy of ALGB (acute leukemia group B)].
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; M | 1976 |
5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combin | 1976 |
[Results with new cytotoxic agents].
Topics: Carmustine; Dacarbazine; Gastrointestinal Neoplasms; Humans; Melanoma; Remission, Spontaneous; Triaz | 1976 |
Treatment of acute leukemia in adults.
Topics: Adolescent; Adult; Aged; Asparaginase; Carmustine; Child; Cytarabine; Daunorubicin; Female; Humans; | 1975 |
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Brain Neoplasms; Carmustine; Child; Child, Presc | 1976 |
1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Topics: Carmustine; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Lar | 1975 |
Some aspects of host response to levamisole after chemotherapy in a murine leukemia.
Topics: Animals; Carmustine; Immunity, Cellular; Leukemia, Experimental; Levamisole; Male; Mice; Mice, Inbre | 1975 |
Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride.
Topics: Adjuvants, Immunologic; Animals; Carmustine; Graft Rejection; Immunosuppressive Agents; Leukemia, Ex | 1975 |
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Topics: Adult; Aged; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lu | 1975 |
[Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].
Topics: Adult; Bone Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Humans; Male; Mel | 1976 |
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas | 1973 |
Cancer of the gastrointestinal tract. Chemotherapy.
Topics: Antineoplastic Agents; Camptothecin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Therapy, Combi | 1974 |
Combination chemotherapy for spontaneous AKR lymphoma.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chem | 1974 |
Treatment of Hodgkin's disease and other malignant lymphomas.
Topics: Alkylating Agents; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; | 1973 |
Combined drug and immunostimulation therapy against a syngeneic murine leukemia.
Topics: Animals; BCG Vaccine; Carmustine; Corynebacterium; Diethylamines; Evaluation Studies as Topic; Fluor | 1974 |
BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice.
Topics: Animals; BCG Vaccine; Carmustine; Cell Line; Dose-Response Relationship, Drug; Leukemia, Experimenta | 1973 |
Eastern cooperative oncology group studies.
Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mech | 1973 |
Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia.
Topics: Animals; BCG Vaccine; Carmustine; Leukemia, Experimental; Male; Mice; Moloney murine leukemia virus; | 1973 |
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dacti | 1973 |
Brief communication: Cure of murine leukemia with drug and interferon treatment.
Topics: Animals; Carmustine; Interferons; Leukemia, Experimental; Male; Mice; Remission, Spontaneous | 1973 |
[Progress in combination chemotherapy of malignant lymphomas (author's transl)].
Topics: Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Nitr | 1973 |
Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.
Topics: Adjuvants, Immunologic; Animals; Carmustine; Graft Rejection; Leukemia, Experimental; Leukemia, Lymp | 1973 |
Influence of age of host on the chemotherapy of murine myeloma LCP-1.
Topics: Age Factors; Aging; Alkylating Agents; Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; | 1974 |
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
Topics: Adult; Aged; Amides; Antibody Formation; Antineoplastic Agents; BCG Vaccine; Carmustine; Drug Therap | 1974 |